DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled
DNA X entered a financing with DNA Holdings to raise $8.1 million through a private placement of Series B Convertible Preferred Stock, comprising $5.0 million in cash and cancellation of $3.1 million of a recent note. The preferred shares automatically convert to common stock after stockholder appr…